Treatment dropout among veterans and their families: Quantitative and qualitative findings.
Treatment dropout among veterans and their families: Quantitative and qualitative findings.
复制标题
DOI:
10.1037/tra0001109
复制
发表时间:
2022-05
期刊:
影响因子:
--
通讯作者:
Neria Y
中科院分区:
文献类型:
--
作者:
Amsalem D;Lopez-Yianilos A;Lowell A;Pickover AM;Arnon S;Zhu X;Suarez-Jimenez B;Ryba M;Bergman M;Such S;Zalman H;Sanchez-Lacay A;Lazarov A;Markowitz JC;Neria Y
Psychotherapy non-completion rates for veterans and their families are high. This study sought to 1) measure non-completion rates of such patients at a university-based treatment center, 2) compare veteran and family member attrition rates, 3) identify dropout predictors, and 4) explore clinicians’ perspectives on treatment non-completion. Using quantitative and qualitative approaches, we analyzed demographic and clinical characteristics of 141 patients (90 military veterans; 51 family members) in a university treatment center. We defined dropout as not completing the time-limited therapy contract. Reviewing semi-structured interview data assessing clinicians’ perspectives on their patients’ dropout, three independent raters agreed on key themes, with interrater coefficient kappa range 0.74 to 1. Patient attrition was 24%, not differing significantly between veterans and family members. Diagnosis of major depression (MDD) and exposure-based therapies predicted non-completion, as did higher baseline Hamilton Depression Rating Scale (HDRS) total scores, severe depression (HDRS>20), lack of Beck Depression Inventory weekly improvement, and history of military sexual trauma. Clinicians mostly attributed non-completion to patient difficulties coping with intense emotions, especially in exposure-based therapies. Non-completion rate at this study appeared relatively low compared to other veteran-based treatment centers, if still unfortunately substantial. Patients with comorbid MDD/PTSD and exposure-based therapies carried greater non-completion risk due to the MDD component, and this should be considered in treatment planning. Ongoing discussion of dissatisfaction and patient discontinuation, in the context of a strong therapeutic alliance, might reduce non-completion in this at-risk population.
登录
查看更多内容
影响因子:
22.8
作者:
Clinton, DN
通讯作者:
Clinton, DN
影响因子:
2.7
作者:
Leon, Andrew C.;Demirtas, Hakan;Hedeker, Donald
通讯作者:
Hedeker, Donald
影响因子:
3.8
作者:
Lowell, Ari;Lopez-Yianilos, Andrea;Neria, Yuval
通讯作者:
Neria, Yuval
影响因子:
2.3
作者:
Garcia, Hector A.;Kelley, Lance P.;Lee, Shuko
通讯作者:
Lee, Shuko
影响因子:
7.4
作者:
Gros, Daniel F.;Price, Matthew;Acierno, Ron
通讯作者:
Acierno, Ron